Learn More
Invitrogen™ Glypican 3 Monoclonal Antibody (GT2473)

Description
Keep as concentrated solution. Predicted reactivity: Chimpanzee (96%), Bovine (81%). Positive Control: HepG2, HepG2 (24 μg/mL Tunicamycin treatment for 16 hr). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
Specifications
Specifications
| Antigen | Glypican 3 |
| Applications | Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry |
| Classification | Monoclonal |
| Clone | GT2473 |
| Concentration | 0.4 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 20% glycerol and no preservative; pH 7 |
| Gene | GPC3 |
| Gene Accession No. | P51654 |
| Gene Alias | defective in Simpson-Golabi-Behmel overgrowth syndrome; DGSX; glypican 3; glypican proteoglycan 3; glypican-3; Glypican-3 alpha subunit; Glypican-3 beta subunit; Gpc3; GTR22; GTR2-2; heparan sulphate proteoglycan; intestinal protein OCI-5; MXR7; OCI5; OCI-5; proteoglycan GPC3; SDYS; secreted glypican-3; SGB; SGBS; SGBS1 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.